ENZ
Enzo Biochem, Inc.
Delisted
ENZ was delisted on the 17th of April, 2025.
51 hedge funds and large institutions have $62M invested in Enzo Biochem, Inc. in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
14% less funds holding
Funds holding: 59 → 51 (-8)
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Holders
51
Holding in Top 10
3
Calls
$253K
Puts
$155K
Top Buyers
| 1 | +$1.36M | |
| 2 | +$838K | |
| 3 | +$639K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$186K |
| 5 |
SFG
SNS Financial Group
Minneapolis,
Minnesota
|
+$181K |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$873K | |
| 3 | -$242K | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$190K |
| 5 |
Two Sigma Advisers
New York
|
-$164K |